Bumper Offer - Urjas oil Just @ Rs. 1
Mirtaz MD 30 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Depression.
The optimal dosage of Mirtaz MD 30 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Mirtaz MD 30 Tablet include Dry Mouth, Headache, Weight gain. Some other side effects of Mirtaz MD 30 Tablet have been listed ahead. Normally, these side effects of Mirtaz MD 30 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Mirtaz MD 30 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Mirtaz MD 30 Tablet related warnings talks about Mirtaz MD 30 Tablet's effects on the liver, heart and kidney.
Mirtaz MD 30 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mirtaz MD 30 Tablet in conditions like Suicidal Tendency, Kidney Disease, Heart Disease. Other conditions have been mentioned below in the Mirtaz MD 30 Tablet contraindications section.
Drug reaction of Mirtaz MD 30 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Mirtaz MD 30 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Mirtaz MD 30 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Mirtaz MD 30 Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Mirtaz MD 30 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Mirtaz. It is best to stop taking Mirtaz immediately and inform your doctor if you notice any discomfort.
Is the use of Mirtaz MD 30 Tablet safe during breastfeeding?
Mirtaz may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Mirtaz MD 30 Tablet on the Kidneys?
Very few cases of side effects of Mirtaz on kidney have been reported.
What is the effect of Mirtaz MD 30 Tablet on the Liver?
Mirtaz is rarely harmful for the liver.
What is the effect of Mirtaz MD 30 Tablet on the Heart?
Very few cases of side effects of Mirtaz on the heart have been reported.
Mirtaz MD 30 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mirtaz MD 30 Tablet unless your doctor advises you to do so -
Is this Mirtaz MD 30 Tablet habit forming or addictive?
No, you will not get addicted to Mirtaz MD 30 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mirtaz MD 30 Tablet can make you feel drowsy.
Is it safe?
Mirtaz MD 30 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, Mirtaz MD 30 Tablet is useful in treating mental disorders.
Interaction between Food and Mirtaz MD 30 Tablet
It is safe to take Mirtaz MD 30 Tablet with food.
Interaction between Alcohol and Mirtaz MD 30 Tablet
Taking Mirtaz MD 30 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 865-866
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462-463
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Remeron® (mirtazapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 865-866
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462-463
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Remeron® (mirtazapine)
